Endophthalmitis in patients with disseminated fungal disease

Stephen S Feman; John C Nichols; Sophia M Chung; Todd A Theobald

Back

Journal article

Endophthalmitis in patients with disseminated fungal disease

Stephen S Feman, John C Nichols, Sophia M Chung and Todd A Theobald

Transactions of the American Ophthalmological Society, Vol.100, pp.67-71

2002

PMCID: PMC1358948

PMID: 12545679

View Online

Abstract

Fungal endophthalmitis caused by dissemination from extraocular fungal infections has been reported to vary between 9% and 45%. However, recent clinical experience disagrees with that. This study is an investigation of patients in an inner city teaching hospital, the risks associated with endogenous fungal endophthalmitis, and this incidence. All ophthalmology consultations between February 1995 and August 2000 that might be associated with disseminated fungal infection were examined in a prospective manner. Patients were excluded if there was no evidence of a positive fungal culture from any site at any time. Visual symptoms were recorded along with ophthalmologic and systemic examination features. Information was gathered, including the identity of cultured organisms, the sites from which the organisms were obtained, and the patients' disposition. During this interval, 170 consultation requests contained the words "endophthalmitis" or "retinitis" and/or indicated concern about disseminated fungal infections. Extraocular fungal infections were found in 114 patients, but only 82 of them had evidence of systemic dissemination. Some patients had more than one organism. The following are listed in decreasing frequency of occurrence: Candida albicans, Torulopsis glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, Aspergillus niger, and others. Only two patients had evidence of chorioretinitis and progressed to fungal endophthalmitis. Endophthalmitis was rare among these patients with known fungal infections. Less than 2% had any related ophthalmic manifestations. Nevertheless, since treatment can save vision, evidence of intraocular infection should be sought as eagerly as before.

Adolescent

Adult

Aged

Aged, 80 and over

Antifungal Agents - therapeutic use

Aspergillosis - complications

Aspergillosis - epidemiology

Aspergillosis - therapy

Aspergillus niger - isolation & purification

Candida - isolation & purification

Candidiasis - complications

Candidiasis - epidemiology

Candidiasis - therapy

Combined Modality Therapy

Endophthalmitis - epidemiology

Endophthalmitis - etiology

Endophthalmitis - therapy

Eye Infections, Fungal - epidemiology

Eye Infections, Fungal - etiology

Eye Infections, Fungal - therapy

Female

Fungemia - complications

Fungemia - epidemiology

Fungemia - therapy

Humans

Incidence

Male

Middle Aged

Prospective Studies

Risk Factors

Vitrectomy

Details

Title: Subtitle: Endophthalmitis in patients with disseminated fungal disease
Creators: Stephen S Feman - Department of Ophthalmology, Saint Louis University Health Sciences Center, St Louis, Missouri, USA
John C Nichols
Sophia M Chung - University of Iowa, Neurology
Todd A Theobald
Resource Type: Journal article
Publication Details: Transactions of the American Ophthalmological Society, Vol.100, pp.67-71
PMID: 12545679
PMCID: PMC1358948
ISSN: 0065-9533
eISSN: 1545-6110
Language: English
Date published: 2002
Academic Unit: Neurology; Ophthalmology and Visual Sciences
Record Identifier: 9984112435802771

Metrics

14 Record Views